ARTVArtiva Biotherapeutics, Inc.
- Market cap
- $300.67M
- as of 2026-10-23
- Latest close
- $6.15
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2024-07-22
Dashed line = amended filing (Form 4/A)
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Aslan FredChief Executive Officer | Oct 6 | Oct 7 | S | 23,463 | $7.20 | Sale −$168,880 | 1,519,606 | Yes | Form 4 |
| Bush JenniferCOO, CLO, Compliance Officer | Oct 5 | Oct 6 | S | 8,370 | $6.84 | Sale −$57,227 | 366,159 | No | Form 4 |
| Horan ChristopherChief Tech Operations Officer | Oct 5 | Oct 6 | S | 10,340 | $6.84 | Sale −$70,697 | 312,744 | No | Form 4 |
| Aslan FredChief Executive Officer | Oct 5 | Oct 6 | S | 61,696 | $6.84 | Sale −$421,828 | 1,543,069 | No | Form 4 |
| Banerjee SubhashisChief Medical Officer | Oct 5 | Oct 6 | S | 1,099 | $6.84 | Sale −$7,514 | 169,848 | No | Form 4 |
| Aslan FredChief Executive Officer | Sep 15 | Sep 15 | A | 110,000 | $0.00 | $0 | 1,604,765 | No | Form 4 |
| Aslan FredChief Executive Officer | Sep 15 | Sep 15 | A · derivative | 315,000 | $8.91 | $2,806,650 | 315,000 | No | Form 4 |
| Moore Alison | Sep 10 | Sep 14 | A · derivative | 16,250 | $10.42 | $169,325 | 16,250 | No | Form 4 |
| Baker Daniel G. | Sep 10 | Sep 14 | A · derivative | 16,250 | $10.42 | $169,325 | 16,250 | No | Form 4 |
| Daniels Brian | Sep 10 | Sep 14 | A · derivative | 16,250 | $10.42 | $169,325 | 16,250 | No | Form 4 |
| Hougen Elizabeth L | Sep 10 | Sep 14 | A · derivative | 16,250 | $10.42 | $169,325 | 16,250 | No | Form 4 |
| Sorg Elaine K. | Sep 10 | Sep 14 | A · derivative | 16,250 | $10.42 | $169,325 | 16,250 | No | Form 4 |
| Stoppel Laura | Sep 10 | Sep 14 | A · derivative | 16,250 | $10.42 | $169,325 | 16,250 | No | Form 4 |
| Aslan FredChief Executive Officer | Sep 10 | Sep 14 | A | 45,000 | $0.00 | $0 | 1,494,765 | No | Form 4 |
| Aslan FredChief Executive Officer | Sep 10 | Sep 14 | A · derivative | 155,000 | $10.42 | $1,615,100 | 155,000 | No | Form 4 |
| Kolchinsky Peter | Sep 10 | Sep 14 | A · derivative | 16,250 | $10.42 | $169,325 | 16,250 | No | Form 4 |
| Banerjee SubhashisChief Medical Officer | Sep 9 | Sep 11 | A | 30,000 | $0.00 | $0 | 170,947 | No | Form 4 |
| Banerjee SubhashisChief Medical Officer | Sep 9 | Sep 11 | A · derivative | 85,000 | $10.79 | $917,150 | 85,000 | No | Form 4 |
| Bush JenniferCOO, CLO, Compliance Officer | Sep 9 | Sep 11 | A | 45,000 | $0.00 | $0 | 374,529 | No | Form 4 |
| Bush JenniferCOO, CLO, Compliance Officer | Sep 9 | Sep 11 | A · derivative | 135,000 | $10.79 | $1,456,650 | 135,000 | No | Form 4 |
| Horan ChristopherChief Tech Operations Officer | Sep 9 | Sep 11 | A | 40,000 | $0.00 | $0 | 323,084 | No | Form 4 |
| Horan ChristopherChief Tech Operations Officer | Sep 9 | Sep 11 | A · derivative | 120,000 | $10.79 | $1,294,800 | 120,000 | No | Form 4 |
| Miralles Gines DiegoPresident & Head of R&D | Sep 9 | Sep 11 | A | 45,000 | $0.00 | $0 | 122,500 | No | Form 4 |
| Miralles Gines DiegoPresident & Head of R&D | Sep 9 | Sep 11 | A · derivative | 135,000 | $10.79 | $1,456,650 | 135,000 | No | Form 4 |
| Aslan FredChief Executive Officer | Sep 8 | Sep 9 | S | 23,429 | $10.92 | Sale −$255,845 | 1,449,765 | Yes | Form 4 |
| Moore Alison | Sep 8 | Sep 8 | A · derivative | 13,750 | $10.88 | $149,600 | 13,750 | No | Form 4 |
| Baker Daniel G. | Sep 8 | Sep 8 | A · derivative | 13,750 | $10.88 | $149,600 | 13,750 | No | Form 4 |
| Daniels Brian | Sep 8 | Sep 8 | A · derivative | 13,750 | $10.88 | $149,600 | 13,750 | No | Form 4 |
| Hougen Elizabeth L | Sep 8 | Sep 8 | A · derivative | 13,750 | $10.88 | $149,600 | 13,750 | No | Form 4 |
| Sorg Elaine K. | Sep 8 | Sep 8 | A · derivative | 13,750 | $10.88 | $149,600 | 13,750 | No | Form 4 |
| Stoppel Laura | Sep 8 | Sep 8 | A · derivative | 13,750 | $10.88 | $149,600 | 13,750 | No | Form 4 |
| Kolchinsky Peter | Sep 8 | Sep 8 | A · derivative | 13,750 | $10.88 | $149,600 | 13,750 | No | Form 4 |
| Aslan FredChief Executive Officer | Sep 3 | Sep 4 | S | 61,888 | $11.16 | Sale −$690,670 | 1,473,194 | No | Form 4 |
| Banerjee SubhashisChief Medical Officer | Sep 3 | Sep 4 | S | 1,100 | $11.16 | Sale −$12,276 | 140,947 | No | Form 4 |
| Bush JenniferCOO, CLO, Compliance Officer | Sep 3 | Sep 4 | S | 8,391 | $11.16 | Sale −$93,644 | 329,529 | No | Form 4 |
| Horan ChristopherChief Tech Operations Officer | Sep 3 | Sep 4 | S | 10,366 | $11.16 | Sale −$115,685 | 283,084 | No | Form 4 |
| Banerjee SubhashisChief Medical Officer | Aug 27 | Aug 31 | M | 5,306 | $1.92 | $10,188 | 150,269 | Yes | Form 4 |
| Banerjee SubhashisChief Medical Officer | Aug 27 | Aug 31 | S | 8,222 | $12.01 | Sale −$98,746 | 142,047 | Yes | Form 4 |
| Banerjee SubhashisChief Medical Officer | Aug 27 | Aug 31 | M · derivative | 5,306 | $1.92 | $10,188 | 74,265 | Yes | Form 4 |
| Banerjee SubhashisChief Medical Officer | Aug 18 | Aug 19 | M | 429 | $1.92 | $824 | 145,392 | Yes | Form 4 |
| Banerjee SubhashisChief Medical Officer | Aug 18 | Aug 19 | S | 429 | $12.00 | Sale −$5,148 | 144,963 | Yes | Form 4 |
| Banerjee SubhashisChief Medical Officer | Aug 18 | Aug 19 | M · derivative | 429 | $1.92 | $824 | 79,571 | Yes | Form 4 |
| RA Capital Healthcare Fund LP | Jul 31 | Jul 31 | P | 24,944 | $9.93 | Purchase +$247,694 | 17,329,570 | No | Form 4 |
| RA Capital Healthcare Fund LP | Jul 29 | Jul 31 | P | 20,824 | $9.99 | Purchase +$208,032 | 17,304,626 | No | Form 4 |
| RA Capital Nexus Fund III, L.P. | Jul 24 | Jul 28 | P | 41,319 | $9.99 | Purchase +$412,777 | 17,283,802 | No | Form 4 |
| Kolchinsky Peter | Jul 23 | Jul 23 | P | 59,880 | $9.96 | Purchase +$596,405 | 17,242,483 | No | Form 4 |
| Kolchinsky Peter | Jul 22 | Jul 23 | P | 84,124 | $9.93 | Purchase +$835,351 | 17,182,603 | No | Form 4 |
| Kolchinsky Peter | Jul 21 | Jul 23 | P | 120,582 | $9.55 | Purchase +$1,151,558 | 17,098,479 | No | Form 4 |
| RA Capital Nexus Fund, L.P. | Jul 13 | Jul 234/A | P | 6,522 | $8.94 | Purchase +$58,307 | 16,817,543 | No | Form 4/A |
| RA Capital Healthcare Fund LP | Jul 17 | Jul 20 | P | 7,882 | $8.95 | Purchase +$70,544 | 16,977,927 | No | Form 4 |
| RA Capital Healthcare Fund LP | Jul 16 | Jul 20 | P | 152,472 | $8.93 | Purchase +$1,361,575 | 16,970,045 | No | Form 4 |
| Shah Rajeev M. | Jul 13 | Jul 14 | P | 6,552 | $8.94 | Purchase +$58,575 | 16,817,573 | No | Form 4 |
| Shah Rajeev M. | Jul 10 | Jul 14 | P | 15,102 | $8.97 | Purchase +$135,465 | 16,811,021 | No | Form 4 |
| Ra Capital Management, L.P. | Jun 26 | Jun 29 | P | 1,876 | $8.98 | Purchase +$16,846 | 16,795,919 | No | Form 4 |
| Ra Capital Management, L.P. | Jun 25 | Jun 29 | P | 31,000 | $8.88 | Purchase +$275,280 | 16,794,043 | No | Form 4 |
| Kolchinsky Peter | Jun 16 | Jun 16 | P | 124,893 | $8.89 | Purchase +$1,110,299 | 16,763,043 | No | Form 4 |
| Kolchinsky Peter | Jun 15 | Jun 16 | P | 15,414 | $8.99 | Purchase +$138,572 | 16,638,150 | No | Form 4 |
| Kolchinsky Peter | Jun 12 | Jun 16 | P | 391,019 | $8.57 | Purchase +$3,351,033 | 16,622,736 | No | Form 4 |
| RA Capital Nexus Fund, L.P. | Jun 11 | Jun 11 | P | 548,580 | $7.91 | Purchase +$4,339,268 | 16,231,717 | No | Form 4 |
| RA Capital Nexus Fund, L.P. | Jun 10 | Jun 11 | P | 103 | $7.00 | Purchase +$721 | 15,683,137 | No | Form 4 |
| RA Capital Nexus Fund, L.P. | Jun 9 | Jun 11 | P | 479,039 | $6.91 | Purchase +$3,310,159 | 15,683,034 | No | Form 4 |
| GC Corp. | May 11 | May 28 | P | 1,085,069 | $11.52 | Purchase +$12,499,995 | 4,391,969 | No | Form 4 |
| GC Corp. | May 11 | May 28 | P | 347,222 | $11.52 | Purchase +$3,999,997 | 1,607,734 | No | Form 4 |
| Aslan FredChief Executive Officer | May 19 | May 19 | S | 27,116 | $9.01 | Sale −$244,315 | 1,535,082 | No | Form 4 |
| Banerjee SubhashisChief Medical Officer | May 19 | May 19 | S | 7,037 | $9.01 | Sale −$63,403 | 144,963 | No | Form 4 |
| Bush JenniferCOO, CLO, Compliance Officer | May 19 | May 19 | S | 8,790 | $9.01 | Sale −$79,198 | 337,920 | No | Form 4 |
| Horan ChristopherChief Tech Operations Officer | May 19 | May 19 | S | 7,002 | $9.01 | Sale −$63,088 | 293,450 | No | Form 4 |
| Raymon HeatherSVP, Research and Development | May 19 | May 19 | S | 3,095 | $9.01 | Sale −$27,886 | 148,228 | No | Form 4 |
| Miralles Gines DiegoPresident & Head of R&D | May 18 | May 19 | A | 77,500 | $0.00 | $0 | 77,500 | No | Form 4 |
| Miralles Gines DiegoPresident & Head of R&D | May 18 | May 19 | A · derivative | 232,500 | $9.22 | $2,143,650 | 232,500 | No | Form 4 |
| RA Capital Nexus Fund III, L.P. | May 11 | May 13 | P | 6,510,416 | $11.52 | Purchase +$74,999,992 | 15,203,995 | No | Form 4 |
| RA Capital Nexus Fund III, L.P. | May 11 | May 13 | P · derivative | 2,170,138 | $11.52 | Purchase +$24,999,990 | 2,170,138 | No | Form 4 |
| Huston Thad AllenChief Financial Officer | Mar 10 | Mar 10 | A | 220,000 | $0.00 | $0 | 220,000 | No | Form 4 |
| Sorg Elaine K. | Feb 18 | Feb 19 | A · derivative | 27,500 | $4.15 | $114,125 | 27,500 | No | Form 4 |
| Aslan FredPresident and CEO | Feb 15 | Feb 18 | A | 366,850 | $0.00 | $0 | 1,576,798 | No | Form 4 |
| Aslan FredPresident and CEO | Feb 15 | Feb 18 | F | 14,600 | $4.00 | $58,400 | 1,562,198 | No | Form 4 |
| Banerjee SubhashisChief Medical Officer | Feb 15 | Feb 18 | A | 102,000 | $0.00 | $0 | 152,000 | No | Form 4 |
| Bush JenniferCOO, CLO, Secy, Compliance Off | Feb 15 | Feb 18 | A | 117,300 | $0.00 | $0 | 350,225 | No | Form 4 |
| Bush JenniferCOO, CLO, Secy, Compliance Off | Feb 15 | Feb 18 | F | 3,515 | $4.00 | $14,060 | 346,710 | No | Form 4 |
| Horan ChristopherChief Tech Operations Officer | Feb 15 | Feb 18 | A | 117,300 | $0.00 | $0 | 302,639 | No | Form 4 |
| Horan ChristopherChief Tech Operations Officer | Feb 15 | Feb 18 | F | 2,187 | $4.00 | $8,748 | 300,452 | No | Form 4 |
| Raymon HeatherSVP, Research and Development | Feb 15 | Feb 18 | A | 46,000 | $0.00 | $0 | 152,844 | No | Form 4 |
| Raymon HeatherSVP, Research and Development | Feb 15 | Feb 18 | F | 1,521 | $4.00 | $6,084 | 151,323 | No | Form 4 |
| Aslan FredPresident and CEO | Dec 15, 2025 | Dec 15, 2025 | S | 3,187 | $6.00 | Sale −$19,122 | 1,209,948 | Yes | Form 4 |
| Aslan FredPresident and CEO | Dec 12, 2025 | Dec 12, 2025 | A | 869,136 | $0.00 | $0 | 1,213,135 | No | Form 4 |
| Aslan FredPresident and CEO | Dec 12, 2025 | Dec 12, 2025 | D · derivative | 100,577 | $5.01 | $503,891 | not reported | No | Form 4 |
| Aslan FredPresident and CEO | Dec 12, 2025 | Dec 12, 2025 | D · derivative | 51,463 | $5.01 | $257,830 | not reported | No | Form 4 |
| Aslan FredPresident and CEO | Dec 12, 2025 | Dec 12, 2025 | D · derivative | 257,319 | $5.01 | $1,289,168 | not reported | No | Form 4 |
| Aslan FredPresident and CEO | Dec 12, 2025 | Dec 12, 2025 | D · derivative | 26,450 | $5.18 | $137,011 | not reported | No | Form 4 |
| Aslan FredPresident and CEO | Dec 12, 2025 | Dec 12, 2025 | D · derivative | 113,999 | $13.47 | $1,535,567 | not reported | No | Form 4 |
| Aslan FredPresident and CEO | Dec 12, 2025 | Dec 12, 2025 | D · derivative | 319,331 | $12.00 | $3,831,972 | not reported | No | Form 4 |
| Bush JenniferCOO, CLO, Secy, Compliance Off | Dec 12, 2025 | Dec 12, 2025 | A | 84,877 | $0.00 | $0 | 232,925 | No | Form 4 |
| Bush JenniferCOO, CLO, Secy, Compliance Off | Dec 12, 2025 | Dec 12, 2025 | D · derivative | 41,039 | $5.01 | $205,605 | not reported | No | Form 4 |
| Bush JenniferCOO, CLO, Secy, Compliance Off | Dec 12, 2025 | Dec 12, 2025 | D · derivative | 9,119 | $5.01 | $45,686 | not reported | No | Form 4 |
| Bush JenniferCOO, CLO, Secy, Compliance Off | Dec 12, 2025 | Dec 12, 2025 | D · derivative | 14,202 | $5.18 | $73,566 | not reported | No | Form 4 |
| Bush JenniferCOO, CLO, Secy, Compliance Off | Dec 12, 2025 | Dec 12, 2025 | D · derivative | 20,519 | $13.47 | $276,391 | not reported | No | Form 4 |
| Horan ChristopherChief Tech Operations Officer | Dec 12, 2025 | Dec 12, 2025 | A | 107,156 | $0.00 | $0 | 185,339 | No | Form 4 |
| Horan ChristopherChief Tech Operations Officer | Dec 12, 2025 | Dec 12, 2025 | D · derivative | 77,519 | $5.01 | $388,370 | not reported | No | Form 4 |
| Horan ChristopherChief Tech Operations Officer | Dec 12, 2025 | Dec 12, 2025 | D · derivative | 9,119 | $5.01 | $45,686 | not reported | No | Form 4 |
| Horan ChristopherChief Tech Operations Officer | Dec 12, 2025 | Dec 12, 2025 | D · derivative | 20,519 | $13.47 | $276,391 | not reported | No | Form 4 |
| Raymon HeatherSVP, Research and Development | Dec 12, 2025 | Dec 12, 2025 | A | 67,253 | $0.00 | $0 | 106,844 | No | Form 4 |
| Raymon HeatherSVP, Research and Development | Dec 12, 2025 | Dec 12, 2025 | D · derivative | 18,239 | $5.14 | $93,748 | not reported | No | Form 4 |
| Raymon HeatherSVP, Research and Development | Dec 12, 2025 | Dec 12, 2025 | D · derivative | 12,539 | $5.01 | $62,820 | not reported | No | Form 4 |
| Raymon HeatherSVP, Research and Development | Dec 12, 2025 | Dec 12, 2025 | D · derivative | 14,819 | $5.01 | $74,243 | not reported | No | Form 4 |
| Raymon HeatherSVP, Research and Development | Dec 12, 2025 | Dec 12, 2025 | D · derivative | 11,399 | $5.18 | $59,047 | not reported | No | Form 4 |
| Raymon HeatherSVP, Research and Development | Dec 12, 2025 | Dec 12, 2025 | D · derivative | 10,259 | $13.47 | $138,189 | not reported | No | Form 4 |
| Aslan FredPresident and CEO | Nov 17, 2025 | Nov 17, 2025 | S | 6,375 | $3.38 | Sale −$21,548 | 343,999 | Yes | Form 4 |
| Aslan FredPresident and CEO | Nov 15, 2025 | Nov 17, 2025 | F | 6,347 | $3.25 | $20,628 | 350,374 | Yes | Form 4 |
| Krishnamohan NehaChief Financial Officer | Nov 15, 2025 | Nov 17, 2025 | F | 3,490 | $3.25 | $11,343 | 99,356 | No | Form 4 |
| Bush JenniferCOO, CLO, Secy, Compliance Off | Nov 15, 2025 | Nov 17, 2025 | F | 3,055 | $3.25 | $9,929 | 148,048 | No | Form 4 |
| Horan ChristopherChief Tech Operations Officer | Nov 15, 2025 | Nov 17, 2025 | F | 1,899 | $3.25 | $6,172 | 78,183 | No | Form 4 |
| Raymon HeatherSVP, Research and Development | Nov 15, 2025 | Nov 17, 2025 | F | 1,375 | $3.25 | $4,469 | 39,591 | No | Form 4 |
| Aslan FredPresident and CEO | Oct 17, 2025 | Oct 17, 2025 | S | 25,500 | $6.00 | Sale −$153,000 | 356,721 | Yes | Form 4 |
| Horan ChristopherChief Tech Operations Officer | Aug 15, 2025 | Aug 18, 2025 | F | 3,577 | $2.75 | $9,837 | 80,082 | No | Form 4 |
| Bush JenniferCOO, CLO, Secy, Compliance Off | Aug 15, 2025 | Aug 18, 2025 | F | 6,409 | $2.75 | $17,625 | 151,103 | No | Form 4 |
| Krishnamohan NehaChief Financial Officer | Aug 15, 2025 | Aug 18, 2025 | F | 5,813 | $2.75 | $15,986 | 102,846 | No | Form 4 |
| Raymon HeatherSVP, Research and Development | Aug 15, 2025 | Aug 18, 2025 | F | 1,639 | $2.75 | $4,507 | 40,966 | No | Form 4 |
| Aslan FredPresident and CEO | Aug 15, 2025 | Aug 18, 2025 | S | 25,500 | $2.73 | Sale −$69,615 | 386,693 | Yes | Form 4 |
| Aslan FredPresident and CEO | Aug 15, 2025 | Aug 18, 2025 | F | 4,472 | $2.75 | $12,298 | 382,221 | Yes | Form 4 |
| Horan ChristopherChief Tech Operations Officer | May 15, 2025 | Aug 18, 2025 | F | 1,341 | $2.13 | $2,856 | 83,659 | No | Form 4 |
| Bush JenniferCOO, CLO, Secy, Compliance Off | May 15, 2025 | Aug 18, 2025 | F | 1,937 | $2.13 | $4,126 | 157,512 | No | Form 4 |
| Krishnamohan NehaChief Financial Officer | May 15, 2025 | Aug 18, 2025 | F | 1,341 | $2.13 | $2,856 | 108,659 | No | Form 4 |
| Raymon HeatherSVP, Research and Development | May 15, 2025 | Aug 18, 2025 | F | 745 | $2.13 | $1,587 | 42,605 | No | Form 4 |
| Aslan FredPresident and CEO | May 15, 2025 | Aug 18, 2025 | F | 4,472 | $2.13 | $9,525 | 412,193 | Yes | Form 4 |
| Daniels Brian | Jun 24, 2025 | Jun 26, 2025 | A · derivative | 13,750 | $1.61 | $22,138 | 13,750 | No | Form 4 |
| Miralles Gines Diego | Jun 24, 2025 | Jun 26, 2025 | A · derivative | 13,750 | $1.61 | $22,138 | 13,750 | No | Form 4 |
| Hougen Elizabeth L | Jun 24, 2025 | Jun 26, 2025 | A · derivative | 13,750 | $1.61 | $22,138 | 13,750 | No | Form 4 |
| Baker Daniel G. | Jun 24, 2025 | Jun 26, 2025 | A · derivative | 13,750 | $1.61 | $22,138 | 13,750 | No | Form 4 |
| Moore Alison | Jun 24, 2025 | Jun 26, 2025 | A · derivative | 13,750 | $1.61 | $22,138 | 13,750 | No | Form 4 |
| Stoppel Laura | Jun 24, 2025 | Jun 26, 2025 | A · derivative | 13,750 | $1.61 | $22,138 | 13,750 | No | Form 4 |
| Ra Capital Management, L.P. | Jun 24, 2025 | Jun 26, 2025 | A · derivative | 13,750 | $1.61 | $22,138 | 13,750 | No | Form 4 |
| Banerjee SubhashisChief Medical Officer | Apr 8, 2025 | Apr 25, 2025 | A | 50,000 | $0.00 | $0 | 50,000 | No | Form 4 |
| Banerjee SubhashisChief Medical Officer | Apr 8, 2025 | Apr 25, 2025 | A · derivative | 80,000 | $1.92 | $153,600 | 80,000 | No | Form 4 |
| Aslan FredPresident and CEO | Mar 5, 2025 | Mar 7, 2025 | A | 200,000 | $0.00 | $0 | 416,665 | No | Form 4 |
| Bush JenniferCOO, CLO, Secy, Compliance Off | Feb 26, 2025 | Feb 28, 2025 | A | 86,650 | $0.00 | $0 | 159,449 | No | Form 4 |
| Krishnamohan NehaChief Financial Officer | Feb 26, 2025 | Feb 28, 2025 | A | 60,000 | $0.00 | $0 | 110,000 | No | Form 4 |
| Horan ChristopherChief Tech Operations Officer | Feb 26, 2025 | Feb 28, 2025 | A | 60,000 | $0.00 | $0 | 85,000 | No | Form 4 |
| Graef ThorstenChief Medical Officer | Feb 26, 2025 | Feb 28, 2025 | A | 60,000 | $0.00 | $0 | 80,000 | No | Form 4 |
| Raymon HeatherSVP, Research and Development | Feb 26, 2025 | Feb 28, 2025 | A | 33,350 | $0.00 | $0 | 43,350 | No | Form 4 |
| Baker Daniel G. | Jan 28, 2025 | Jan 29, 2025 | A · derivative | 27,500 | $5.56 | $152,900 | 27,500 | No | Form 4 |
| Moore Alison | Oct 21, 2024 | Oct 22, 2024 | A · derivative | 27,500 | $10.48 | $288,200 | 27,500 | No | Form 4 |
| Bush JenniferCOO, CLO, Secy, Compliance Off | Sep 12, 2024 | Sep 13, 2024 | A | 50,000 | $0.00 | $0 | 72,799 | No | Form 4 |
| Krishnamohan NehaChief Financial Officer | Sep 12, 2024 | Sep 13, 2024 | A | 50,000 | $0.00 | $0 | 50,000 | No | Form 4 |
| Horan ChristopherChief Tech Operations Officer | Sep 12, 2024 | Sep 13, 2024 | A | 25,000 | $0.00 | $0 | 25,000 | No | Form 4 |
| Graef ThorstenChief Medical Officer | Sep 12, 2024 | Sep 13, 2024 | A | 20,000 | $0.00 | $0 | 20,000 | No | Form 4 |
| Raymon HeatherSVP, Research and Development | Sep 12, 2024 | Sep 13, 2024 | A | 10,000 | $0.00 | $0 | 10,000 | No | Form 4 |
| 5AM Partners VI, LLC | Jul 22, 2024 | Jul 24, 2024 | C | 1,058,284 | not reported | not reported | 1,058,284 | No | Form 4 |
| 5AM Partners VI, LLC | Jul 22, 2024 | Jul 24, 2024 | J | 112,966 | $10.20 | $1,152,253 | 1,171,250 | No | Form 4 |
| 5AM Partners VI, LLC | Jul 22, 2024 | Jul 24, 2024 | J | 348,721 | $10.20 | $3,556,954 | 348,721 | No | Form 4 |
| 5AM Partners VI, LLC | Jul 22, 2024 | Jul 24, 2024 | P | 833,333 | $12.00 | Purchase +$9,999,996 | 1,182,054 | No | Form 4 |
| 5AM Partners VI, LLC | Jul 22, 2024 | Jul 24, 2024 | C · derivative | 843,592 | not reported | not reported | not reported | No | Form 4 |
| 5AM Partners VI, LLC | Jul 22, 2024 | Jul 24, 2024 | C · derivative | 214,692 | not reported | not reported | not reported | No | Form 4 |
| Kolchinsky Peter | Jul 22, 2024 | Jul 24, 2024 | C | 725,391 | not reported | not reported | 725,391 | No | Form 4 |
| Kolchinsky Peter | Jul 22, 2024 | Jul 24, 2024 | C | 264,571 | not reported | not reported | 264,571 | No | Form 4 |
| Kolchinsky Peter | Jul 22, 2024 | Jul 24, 2024 | C | 68,320 | not reported | not reported | 68,320 | No | Form 4 |
| Kolchinsky Peter | Jul 22, 2024 | Jul 24, 2024 | J | 323,181 | $10.20 | $3,296,446 | 1,048,572 | No | Form 4 |
| Kolchinsky Peter | Jul 22, 2024 | Jul 24, 2024 | J | 138,506 | $10.20 | $1,412,761 | 138,506 | No | Form 4 |
| Kolchinsky Peter | Jul 22, 2024 | Jul 24, 2024 | P | 7,645,007 | $12.00 | Purchase +$91,740,084 | 8,693,579 | No | Form 4 |
| Kolchinsky Peter | Jul 22, 2024 | Jul 24, 2024 | P | 688,326 | $12.00 | Purchase +$8,259,912 | 826,832 | No | Form 4 |
| Kolchinsky Peter | Jul 22, 2024 | Jul 24, 2024 | C · derivative | 564,372 | not reported | not reported | not reported | No | Form 4 |
| Kolchinsky Peter | Jul 22, 2024 | Jul 24, 2024 | C · derivative | 210,898 | not reported | not reported | not reported | No | Form 4 |
| Kolchinsky Peter | Jul 22, 2024 | Jul 24, 2024 | C · derivative | 68,320 | not reported | not reported | not reported | No | Form 4 |
| Kolchinsky Peter | Jul 22, 2024 | Jul 24, 2024 | C · derivative | 161,019 | not reported | not reported | not reported | No | Form 4 |
| Kolchinsky Peter | Jul 22, 2024 | Jul 24, 2024 | C · derivative | 53,673 | not reported | not reported | not reported | No | Form 4 |
| Venbio Global Strategic Gp III, Ltd | Jul 22, 2024 | Jul 22, 2024 | C | 843,592 | not reported | not reported | 843,592 | No | Form 4 |
| Venbio Global Strategic Gp III, Ltd | Jul 22, 2024 | Jul 22, 2024 | C | 214,692 | not reported | not reported | 1,058,284 | No | Form 4 |
| Venbio Global Strategic Gp III, Ltd | Jul 22, 2024 | Jul 22, 2024 | J | 461,687 | not reported | not reported | 1,519,971 | No | Form 4 |
| Venbio Global Strategic Gp III, Ltd | Jul 22, 2024 | Jul 22, 2024 | P | 416,666 | $12.00 | Purchase +$4,999,992 | 1,936,637 | No | Form 4 |
| Venbio Global Strategic Gp III, Ltd | Jul 22, 2024 | Jul 22, 2024 | C · derivative | 843,592 | not reported | not reported | not reported | No | Form 4 |
| Venbio Global Strategic Gp III, Ltd | Jul 22, 2024 | Jul 22, 2024 | C · derivative | 214,692 | not reported | not reported | not reported | No | Form 4 |
| Aslan FredPresident and CEO | Jul 22, 2024 | Jul 22, 2024 | A | 228,905 | $0.00 | $0 | 228,905 | No | Form 4 |
| Huh Yong-Jun | Jul 22, 2024 | Jul 22, 2024 | C | 667,185 | not reported | not reported | 1,016,022 | No | Form 4 |
| Huh Yong-Jun | Jul 22, 2024 | Jul 22, 2024 | C | 330,095 | not reported | not reported | 1,346,117 | No | Form 4 |
| Huh Yong-Jun | Jul 22, 2024 | Jul 22, 2024 | J | 294,117 | $10.20 | $2,999,993 | 1,640,234 | No | Form 4 |
| Huh Yong-Jun | Jul 22, 2024 | Jul 22, 2024 | P | 1,666,666 | $12.00 | Purchase +$19,999,992 | 3,306,900 | No | Form 4 |
| Huh Yong-Jun | Jul 22, 2024 | Jul 22, 2024 | C | 292,791 | not reported | not reported | 525,349 | No | Form 4 |
| Huh Yong-Jun | Jul 22, 2024 | Jul 22, 2024 | C | 62,181 | not reported | not reported | 587,530 | No | Form 4 |
| Huh Yong-Jun | Jul 22, 2024 | Jul 22, 2024 | J | 256,316 | $10.20 | $2,614,423 | 843,846 | No | Form 4 |
| Huh Yong-Jun | Jul 22, 2024 | Jul 22, 2024 | P | 416,666 | $12.00 | Purchase +$4,999,992 | 1,260,512 | No | Form 4 |
| Huh Yong-Jun | Jul 22, 2024 | Jul 22, 2024 | C · derivative | 667,185 | not reported | not reported | not reported | No | Form 4 |
| Huh Yong-Jun | Jul 22, 2024 | Jul 22, 2024 | C · derivative | 330,095 | not reported | not reported | not reported | No | Form 4 |
| Huh Yong-Jun | Jul 22, 2024 | Jul 22, 2024 | C · derivative | 292,791 | not reported | not reported | not reported | No | Form 4 |
| Huh Yong-Jun | Jul 22, 2024 | Jul 22, 2024 | C · derivative | 62,181 | not reported | not reported | not reported | No | Form 4 |
| GC Cell Corp | Jul 22, 2024 | Jul 22, 2024 | C | 667,185 | not reported | not reported | 1,016,022 | No | Form 4 |
| GC Cell Corp | Jul 22, 2024 | Jul 22, 2024 | C | 330,095 | not reported | not reported | 1,346,117 | No | Form 4 |
| GC Cell Corp | Jul 22, 2024 | Jul 22, 2024 | J | 294,117 | $10.20 | $2,999,993 | 1,640,234 | No | Form 4 |
| GC Cell Corp | Jul 22, 2024 | Jul 22, 2024 | P | 1,666,666 | $12.00 | Purchase +$19,999,992 | 3,306,900 | No | Form 4 |
| GC Cell Corp | Jul 22, 2024 | Jul 22, 2024 | C | 292,791 | not reported | not reported | 525,349 | No | Form 4 |
| GC Cell Corp | Jul 22, 2024 | Jul 22, 2024 | C | 62,181 | not reported | not reported | 587,530 | No | Form 4 |
| GC Cell Corp | Jul 22, 2024 | Jul 22, 2024 | J | 256,316 | $10.20 | $2,614,423 | 843,846 | No | Form 4 |
| GC Cell Corp | Jul 22, 2024 | Jul 22, 2024 | P | 416,666 | $12.00 | Purchase +$4,999,992 | 1,260,512 | No | Form 4 |
| GC Cell Corp | Jul 22, 2024 | Jul 22, 2024 | C · derivative | 667,185 | not reported | not reported | not reported | No | Form 4 |
| GC Cell Corp | Jul 22, 2024 | Jul 22, 2024 | C · derivative | 330,095 | not reported | not reported | not reported | No | Form 4 |
| GC Cell Corp | Jul 22, 2024 | Jul 22, 2024 | C · derivative | 292,791 | not reported | not reported | not reported | No | Form 4 |
| GC Cell Corp | Jul 22, 2024 | Jul 22, 2024 | C · derivative | 62,181 | not reported | not reported | not reported | No | Form 4 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Jul 22, 2024 | Jul 22, 2024 | C | 145,089 | not reported | not reported | 145,089 | No | Form 4 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Jul 22, 2024 | Jul 22, 2024 | J | 49,019 | $10.20 | $499,994 | 194,108 | No | Form 4 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Jul 22, 2024 | Jul 22, 2024 | C · derivative | 145,089 | not reported | not reported | not reported | No | Form 4 |
| Aslan FredPresident and CEO | Jul 18, 2024 | Jul 22, 2024 | A · derivative | 343,811 | $12.00 | $4,125,732 | 343,811 | No | Form 4 |